For the Inventor, By the Inventor

Enter assignee name

Grand Cayman, Cayman Islands

Dart Neuroscience, (Cayman) Ltd.

Calculating rank

USPTO Granted Patents = 41

% Expired Patents = 63.4

Forward Citations = 59

Loading Chart...

Loading Chart...

46 inventors (with patents filed for the assignee):

Alan P Kaplan (23 out of 30 patents)

James Breitenbucher (13 out of 20 patents)

Troy Vickers (12 out of 16 patents)

4. Laurent Gomez (11 out of 31 patents)

5. Terence P Keenan (11 out of 23 patents)

6. Varsha Gupta (9 out of 12 patents)

7. Graeme Freestone (8 out of 9 patents)

8. Tami Jo Marrone (8 out of 8 patents)

9. Andrew Richard Hudson (8 out of 17 patents)

10. Robert Huerta Lemus (7 out of 19 patents)

11. Brian Dyck (7 out of 28 patents)

12. Andrew J McRiner (7 out of 18 patents)

13. Marco Peters (7 out of 11 patents)

14. Rusiko Bourtchouladze (7 out of 14 patents)

15. Michael I Weinhouse (7 out of 12 patents)

Core Competencies:

PDE2 Inhibitors

PDE4 Inhibitors

Cognitive Enhancement

Therapeutic Compounds

Isoxazole Compounds

GlyT1 Inhibitors

Naphthyridine Compounds

Quinoline Compounds

Triazolo Compounds

Thiophene Compounds

Furan Compounds

Pyrazine Compounds

41 patents: Sort by Forward Citations

1. 11186582 - Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as PDE2 inhibitors (2021-11-30),

2. 10501465 - Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitors (2019-12-10),

3. 10376514 - Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6H)-ones (2019-08-13),

4. 10239882 - Substituted 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine compounds as PDE2 inhibitors (2019-03-26),

5. 10105367 - Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-ones (2018-10-23),

6. 10092575 - Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compounds (2018-10-09),

7. 10053467 - Therapeutic isoxazole compounds (2018-08-21),

8. 10040759 - Substituted azetidinyl compounds as GlyT1 inhibitors (2018-08-07),

9. 9956213 - Substituted naphthyridine and quinoline compounds as MAO inhibitors (2018-05-01),

10. 9932345 - Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitors (2018-04-03),

11. 9931318 - Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation (2018-04-03),

12. 9863934 - Screening methods for cognitive enhancers (2018-01-09),

13. 9795591 - Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation (2017-10-24),

14. 9708334 - Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitors (2017-07-18),

15. 9675605 - Substituted naphthyridine and quinoline compounds as MAO inhibitors (2017-06-13),

Company Overview

Dart Neuroscience, (Cayman) Ltd. is a biopharmaceutical company based in Grand Cayman, specializing in the development of innovative therapeutic compounds aimed at enhancing cognitive function. The company focuses on research and development of PDE2 and PDE4 inhibitors, along with various classes of compounds such as isoxazole, azetidinyl, naphthyridine, and quinoline. Dart Neuroscience is dedicated to advancing treatments for cognitive disorders, leveraging its expertise in neuropharmacology to address unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

41 Patents

#26 in Grand Cayman

#31 in Cayman Islands

#16,725 in the World

Grand Cayman, Cayman Islands

Dart Neuroscience, (Cayman) Ltd.

Forward Citations = 59

46 inventors:

Alan P Kaplan (23 out of 30 patents)

James Breitenbucher (13 out of 20 patents)

Troy Vickers (12 out of 16 patents)

4. Laurent Gomez (11 out of 31 patents)

5. Terence P Keenan (11 out of 23 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dart Neuroscience, (Cayman) Ltd.. Retrieved from https://idiyas.com/company/dart-neuroscience-cayman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…